安琪酵母(600298.SH):境外子公司記賬本位幣變更 合併報表淨資產增加17151萬元
格隆匯 11 月 30日丨安琪酵母(600298.SH)公佈,公司目前擁有三家境外子公司:安琪酵母(埃及)有限公司(“安琪埃及”)、安琪酵母(香港)有限公司(“安琪香港”)和安琪酵母(俄羅斯)有限公司(“安琪俄羅斯”),自成立以來分別採用埃鎊、美元和盧布作為記賬本位幣。公司擬自2020年1月1日起將境外子公司記賬本位幣由外幣變更為人民幣。
經測算,自2020年1月1日境外子公司記賬本位幣變更為人民幣,對公司會計報表的影響為:合併報表淨資產增加17151萬元,2020年1-9月淨利潤增加3666萬元。(以上數據未經審計)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.